Related Experiment Video
Updated: Apr 23, 2026
04:14
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
Published on: October 6, 2023
1.4K
Thyrotoxicosis of Pregnancy
Artak Labadzhyan1, Gregory A Brent2, Jerome M Hershman2
1Division of Endocrinology, Cedars-Sinai Medical Center and VA Greater Los Angeles Healthcare System, Los Angeles, California.
Journal of Clinical & Translational Endocrinology
|September 23, 2014
Summary
Diagnosing thyrotoxicosis in pregnancy requires distinguishing it from normal thyroid changes. This review covers diagnosis, fetal risks, and treatment for maternal hyperthyroidism during gestation.
Area of Science:
- Endocrinology
- Obstetrics
- Reproductive Medicine
Background:
- Thyrotoxicosis in pregnancy poses diagnostic challenges, often confused with physiological gestational thyroid dysfunction.
- Accurate differentiation is crucial for optimal maternal and fetal outcomes.
Purpose of the Study:
- To summarize the differential diagnosis of thyrotoxicosis during pregnancy.
- To outline clinical presentation, diagnostic strategies, and management options.
- To review potential adverse fetal effects and treatment recommendations.
Main Methods:
- This is a review article.
- Synthesizing current literature on thyrotoxicosis in pregnancy.
- Focusing on differential diagnosis, clinical features, and management.
Main Results:
- Distinguishing true hyperthyroidism from normal pregnancy-related thyroid changes is key.
- Maternal thyrotoxicosis can lead to adverse fetal and neonatal outcomes.
- Timely and appropriate treatment is essential.
Conclusions:
- Effective management of thyrotoxicosis in pregnancy involves accurate diagnosis and tailored treatment.
- Understanding potential risks to the fetus guides therapeutic decisions.
- This review provides a comprehensive guide for clinicians.
Related Concept Videos
01:25Hyperthyroidism I: Introduction
11
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
11
01:27Hyperthyroidism II: Pathophysiology
10
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
10
01:24Graves Disease II: Pathophysiology
14
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
14
01:28Graves' Disease I: Introduction
13
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
13
01:20Synthesis and Regulation of Thyroid Hormones
7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
01:23Hypothyroidism II: Pathophysiology
12
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
12